Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Oliver Tobin

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Developmental Medicine and Child Neurology|September 25, 2018
Growing the phenotype of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) in childrenW Oliver Tobin
Neurology|September 15, 2021
Early Diagnosis and Treatment Are Associated With Improved Outcomes in Patients With Multiple SclerosisW Oliver Tobin
Continuum (Minneapolis, Minn.)|June 5, 2019
Management of Multiple Sclerosis Symptoms and ComorbiditiesW Oliver Tobin
Blood|July 10, 2025
Redefining risk stratification in pLCHJithma P Abeykoon, W Oliver Tobin
Continuum (Minneapolis, Minn.)|June 2, 2017
Autoimmune Neurology of the Central Nervous SystemW Oliver Tobin, Sean J Pittock
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 5, 2017
Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS - NOW Oliver Tobin, Brian G Weinshenker
Multiple Sclerosis and Related Disorders|November 27, 2020
Cyclophosphamide in treatment of tumefactive multiple sclerosisMahboobeh Fereidan-Esfahani, W Oliver Tobin
Current Neurology and Neuroscience Reports|July 21, 2017
CLIPPERSNicholas L Zalewski, W Oliver Tobin
Ocular Immunology and Inflammation|June 30, 2018
Reply to: "Crowell et al. Idiopathic Central Nervous System Inflammatory Disease in the Setting of HLA-B27 Uveitis"W Oliver Tobin, B Mark Keegan
JAMA Neurology|July 14, 2015
Rituximab Therapy in Neuromyelitis Optica: Moving Toward a Personalized Medicine ApproachW Oliver Tobin, Sean J Pittock
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Developmental Medicine and Child Neurology|September 25, 2018
Growing the phenotype of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) in childrenW Oliver Tobin
Neurology|September 15, 2021
Early Diagnosis and Treatment Are Associated With Improved Outcomes in Patients With Multiple SclerosisW Oliver Tobin
Continuum (Minneapolis, Minn.)|June 5, 2019
Management of Multiple Sclerosis Symptoms and ComorbiditiesW Oliver Tobin
Blood|July 10, 2025
Redefining risk stratification in pLCHJithma P Abeykoon, W Oliver Tobin
Continuum (Minneapolis, Minn.)|June 2, 2017
Autoimmune Neurology of the Central Nervous SystemW Oliver Tobin, Sean J Pittock
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 5, 2017
Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS - NOW Oliver Tobin, Brian G Weinshenker
Multiple Sclerosis and Related Disorders|November 27, 2020
Cyclophosphamide in treatment of tumefactive multiple sclerosisMahboobeh Fereidan-Esfahani, W Oliver Tobin
Current Neurology and Neuroscience Reports|July 21, 2017
CLIPPERSNicholas L Zalewski, W Oliver Tobin
Ocular Immunology and Inflammation|June 30, 2018
Reply to: "Crowell et al. Idiopathic Central Nervous System Inflammatory Disease in the Setting of HLA-B27 Uveitis"W Oliver Tobin, B Mark Keegan
JAMA Neurology|July 14, 2015
Rituximab Therapy in Neuromyelitis Optica: Moving Toward a Personalized Medicine ApproachW Oliver Tobin, Sean J Pittock
Pageof 13